Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Indian J Pharmacol ; 47(1): 80-5, 2015.
Article in English | MEDLINE | ID: mdl-25821316

ABSTRACT

OBJECTIVES: The aim was to investigate the nephroprotective effect of combination of aliskiren (ASK), a direct renin inhibitor and pentoxifylline (PTX), inhibitor of tumor necrotic factor-alpha (TNF-alpha), in rat remnant kidney model of chronic kidney disease (CKD). MATERIALS AND METHODS: Nephrectomized (NPX) rats were treated with ASK (10 mg/kg, p.o.), PTX (100 mg/kg, p.o.), and combination of PTX + ASK once daily for 28 days. We have performed analysis of various renal injury parameters after 4 weeks of treatment. RESULTS: Treatment with PTX, ASK and combination showed significant improvement in urea, creatinine and total protein in plasma when compared with vehicle treated group in NPX rats. ASK and combination of PTX + ASK elicited significant reduction in blood pressure but PTX alone did not produce blood pressure reduction. ASK treatment showed significant elevation in TNF-alpha, whereas PTX and ASK + PTX showed significant reduction in TNF-alpha in plasma. Histopathologically, the extent of the kidney injury was similar in NPX + vehicle and NPX + ASK-treated rats. PTX and ASK + PTX-treated group showed lesser extent of kidney injury. There was good correlation of mRNA expression levels of kidney injury molecule-1 and bradykinin B1 receptor data with histopathological findings in kidney samples and elevated TNF-alpha levels in plasma. CONCLUSIONS: We conclude that combination of PTX + ASK may be better therapeutic intervention for nephroprotection in CKD patients.


Subject(s)
Amides/pharmacology , Fumarates/pharmacology , Kidney Failure, Chronic/drug therapy , Kidney/drug effects , Nephrectomy , Pentoxifylline/pharmacology , Animals , Arterial Pressure/drug effects , Cell Adhesion Molecules/genetics , Cell Adhesion Molecules/metabolism , Creatinine/blood , Disease Models, Animal , Drug Therapy, Combination , Kidney/metabolism , Kidney/pathology , Kidney/physiopathology , Kidney Failure, Chronic/genetics , Kidney Failure, Chronic/metabolism , Kidney Failure, Chronic/pathology , Kidney Failure, Chronic/physiopathology , Male , RNA, Messenger/metabolism , Rats, Sprague-Dawley , Receptor, Bradykinin B1/genetics , Receptor, Bradykinin B1/metabolism , Renin/antagonists & inhibitors , Renin/metabolism , Tumor Necrosis Factor-alpha/antagonists & inhibitors , Tumor Necrosis Factor-alpha/blood , Urea/blood
SELECTION OF CITATIONS
SEARCH DETAIL
...